Florian Meier

Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study

Safety and effectiveness of abatacept in systemic sclerosis: The EUSTAR experience

Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database

Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study

The Role of Innate Immunity in Osteoarthritis: When Our First Line of Defense Goes On the Offensive

Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database

Macrophages in immunoregulation and therapeutics

Systemic sclerosis

Performance of the new ACR/EULAR classification criteria for systemic sclerosis in clinical practice

Osteoarthritis

Anti-arthritic agents: Progress and potential

An update on the pathophysiology of osteoarthritis

Monocytes, Macrophages, and Their Potential Niches in Synovial Joints – Therapeutic Targets in Post-Traumatic Osteoarthritis?

Impaired quality of life in systemic sclerosis and patient perception of the disease: A large international survey

Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: a EUSTAR analysis

Consensus best practice pathway of the UK Scleroderma Study Group: digital vasculopathy in systemic sclerosis

Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease

Diagnosis and Treatment of Hip and Knee Osteoarthritis

Adipokines and Osteoarthritis: Novel Molecules Involved in the Pathogenesis and Progression of Disease

Therapeutic Potential of Quercetin: New Insights and Perspectives for Human Health

Visfatin/Pre-B-cell Colony-enhancing Factor (PBEF), a Proinflammatory and Cell Motility-changing Factor in Rheumatoid Arthritis

Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database

Adiponectin‐mediated changes in effector cells involved in the pathophysiology of rheumatoid arthritis

Current Immunotherapy in Rheumatoid Arthritis